42 related articles for article (PubMed ID: 28453463)
1. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract][Full Text] [Related]
2. miR-206 alleviates LPS-induced inflammatory injury in cardiomyocytes via directly targeting USP33 to inhibit the JAK2/STAT3 signaling pathway.
Dong W; Chen J; Wang Y; Weng J; Du X; Fang X; Liu W; Long T; You J; Wang W; Peng X
Mol Cell Biochem; 2024 Apr; 479(4):929-940. PubMed ID: 37256445
[TBL] [Abstract][Full Text] [Related]
3. Enhanced synergy of pacritinib with temsirolimus and sunitinib in preclinical renal cell carcinoma model by targeting JAK2/STAT pathway.
Mao F; Gao L; Liu L; Tang Y
J Chemother; 2024 May; 36(3):238-248. PubMed ID: 37916436
[TBL] [Abstract][Full Text] [Related]
4. Cryptanshinone extract of Salvia miltiorrhiza stimulates pediatric acute myeloid leukemia stem cell apoptosis and the anti-inflammatory mechanism via accelerating microRNA-211-5p to supress Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway activation.
Ye Q; Ren L; Jiang ZM; Li XY; Wei GY; Ren YF; Ren LH
J Physiol Pharmacol; 2023 Dec; 74(6):. PubMed ID: 38345448
[TBL] [Abstract][Full Text] [Related]
5. Eupatilin ameliorates postmenopausal osteoporosis via elevating microRNA-211-5p and repressing JAK2/STAT3 pathway.
Hong L; Yang C
Environ Toxicol; 2024 Apr; 39(4):2218-2228. PubMed ID: 38130072
[TBL] [Abstract][Full Text] [Related]
6. miR-141-3p Regulates the Proliferation and Apoptosis of Endometrial-Myometrial Interface Smooth Muscle Cells in Adenomyosis Via JAK2/STAT3 Pathway.
Wang S; Duan H; Wang S; Guo Z; Lin Q
Biochem Genet; 2023 Oct; ():. PubMed ID: 37828348
[TBL] [Abstract][Full Text] [Related]
7. YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α.
Takeuchi A; Shiota M; Tatsugami K; Yokomizo A; Kuroiwa K; Dejima T; Tanaka S; Itsumi M; Eto M; Naito S
Cancer Immunol Immunother; 2013 Mar; 62(3):517-27. PubMed ID: 23052245
[TBL] [Abstract][Full Text] [Related]
8. JAK2/STAT3 as a new potential target to manage neurodegenerative diseases: An interactive review.
Panda SP; Kesharwani A; Datta S; Prasanth DSNBK; Panda SK; Guru A
Eur J Pharmacol; 2024 May; 970():176490. PubMed ID: 38492876
[TBL] [Abstract][Full Text] [Related]
9. Trastuzumab-induced human cardiomyocyte damage through the Notch2/JAK2/STAT3 pathway.
Su Z; Liu S; Zou Y; Shan L; Yu M; Xie S; Li X; Jin Y
Clinics (Sao Paulo); 2023; 78():100268. PubMed ID: 37567042
[TBL] [Abstract][Full Text] [Related]
10. Repurposing FDA-approved compounds to target JAK2 for colon cancer treatment.
Chandrasekhar B; Gor R; Ramalingam S; Thiagarajan A; Sohn H; Madhavan T
Discov Oncol; 2024 Jun; 15(1):226. PubMed ID: 38869738
[TBL] [Abstract][Full Text] [Related]
11. Correction: miR-206 alleviates LPS-induced inflammatory injury in cardiomyocytes via directly targeting USP33 to inhibit the JAK2/STAT3 signaling pathway.
Dong W; Chen J; Wang Y; Weng J; Du X; Fang X; Liu W; Long T; You J; Wang W; Peng X
Mol Cell Biochem; 2024 Feb; 479(2):445. PubMed ID: 37432634
[No Abstract] [Full Text] [Related]
12. Heterogeneity of Platelet Derived Growth Factor Pathway Gene Expression Profile Defines Three Distinct Subgroups of Renal Cell Carcinomas.
Ferician AM; Ferician OC; Cumpanas AD; Berzava PL; Nesiu A; Barmayoun A; Cimpean AM
Cancer Genomics Proteomics; 2022; 19(4):477-489. PubMed ID: 35732321
[TBL] [Abstract][Full Text] [Related]
13. Adipogenic Transdifferentiation and Regulatory Factors Promote the Progression and the Immunotherapy Response of Renal Cell Carcinoma: Insights From Integrative Analysis.
Wang S; Wei X; Ji C; Wang Y; Zhang X; Cong R; Song N
Front Oncol; 2022; 12():781932. PubMed ID: 35356208
[TBL] [Abstract][Full Text] [Related]
14. Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.
Patutina OA; Gaponova Miroshnichenko SK; Sen'kova AV; Savin IA; Gladkikh DV; Burakova EA; Fokina AA; Maslov MA; Shmendel' EV; Wood MJA; Vlassov VV; Altman S; Stetsenko DA; Zenkova MA
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32370-32379. PubMed ID: 33288723
[TBL] [Abstract][Full Text] [Related]
15. Activation of the STAT3/microRNA-21 pathway participates in angiotensin II-induced angiogenesis.
Chen LY; Wang X; Qu XL; Pan LN; Wang ZY; Lu YH; Hu HY
J Cell Physiol; 2019 Nov; 234(11):19640-19654. PubMed ID: 30950039
[TBL] [Abstract][Full Text] [Related]
16. AG490, a JAK2-specific inhibitor, downregulates the expression and activity of organic anion transporter-3.
Zhang J; Liu C; You G
J Pharmacol Sci; 2018 Mar; 136(3):142-148. PubMed ID: 29487013
[TBL] [Abstract][Full Text] [Related]
17. The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.
Su Y; Zhao A; Cheng G; Xu J; Ji E; Sun W
Cancer Biomark; 2017 Jul; 19(3):289-296. PubMed ID: 28453463
[TBL] [Abstract][Full Text] [Related]
18. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
Lei J; Xiao JH; Zhang SH; Liu ZQ; Huang K; Luo ZP; Xiao XL; Hong ZD
Mol Med Rep; 2017 Oct; 16(4):4273-4278. PubMed ID: 28765891
[TBL] [Abstract][Full Text] [Related]
19. miRNA-133b and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling pathway in human renal carcinoma cells.
Zhou W; Bi X; Gao G; Sun L
Biomed Pharmacother; 2016 Dec; 84():722-729. PubMed ID: 27710896
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
